問卷

TPIDB > Search Result > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Hematology & Oncology

Division of General Internal Medicine

Division of Thoracic Medicine

Division of Urology

Division of Others-

Division of Obstetrics & Gynecology

National Taiwan University Hospital (在職)

Division of Hematology & Oncology

Division of General Internal Medicine

Division of Thoracic Medicine

National Cheng Kung University Hospital Dou-Liou Branch (在職)

Division of Hematology & Oncology

Division of Hematology & Oncology

Division of General Internal Medicine

更新時間:2023-09-19

蘇五洲Su, Wu-Chou
  • Principal Investigator
  • Clinical Trial Experience (year) 24 years

篩選

List

383Cases

2015-10-01 - 2020-06-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting3Sites

Terminated3Sites

馮思中
Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

張牧新
Taipei Veterans General Hospital

Division of Hematology & Oncology

2023-02-01 - 2026-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2014-08-01 - 2020-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

-

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

2017-09-01 - 2020-09-01

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated1Sites

2021-06-01 - 2025-06-30

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2020-12-14 - 2025-04-30

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2018-12-06 - 2025-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting3Sites

Terminated4Sites

2024-05-01 - 2032-02-29

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2020-07-23 - 2024-02-15

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites